
























As a European Union (EU) candidate country [1], 
Serbia has started the process of approximation to 
the European regulations and standards at all levels 
of health care as defined in the National Plan for the 
Adoption of the Acquis 2014-2018 (NPAA) [2], adopt-
ed in July 2014. As part of this process, Serbia has trans-
posed the major concepts of the EU legislation related 
to communicable diseases and public health threats of 
infectious origin in the Law on Protection of Population 
from Communicable Diseases [3]. Case definitions of 
communicable diseases under surveillance have been 
aligned to the Commission Implementing Decision 
2012/506/EU [4] and functions of National Reference 
Laboratories have been revised to match to current EU 
standards [5].
The challenge facing Serbia at this stage is to achieve 
an effective implementation of this legislation across its 
microbiology system that comprises the national level 
(i.e. the Ministry of Health of the Republic of Serbia 
– MoH and the Institute of Public Health of Serbia – 
IPHS); all nominated National Reference Laboratories 
(NRLs) and public and private primary diagnostic labo-
ratories. A thorough assessment of gaps was needed in 
all those levels, in order to identify priorities and design 
a road map to reach EU standards for the detection 
and/or confirmation of communicable diseases in line 
with EU case definitions in microbiology laboratories 
(including NRLs).
In 2016, Serbia tested an existing EU tool for the 
assessment of laboratory capacity (EULabCap) [6]. 
The EULabCap monitoring tool is composed of 60 
performance indicators grouped into 12 targets which 
are equally distributed across the following three pub-
lic health microbiology system dimensions: primary 
diagnostic testing, national microbiology reference 
laboratory services, and laboratory-based surveillance 
and epidemic response support. It quantifies capabil-
ity and capacity of microbiology laboratories to provide 
essential public health functions, as defined in EU poli-
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Abstract 
Introduction. Italian and Serbian Health authorities performed an in-depth Gap As-
sessment of the Serbian microbiology system in the function of communicable disease 
surveillance using a methodology adapted to context and information needs.
Methods. There were two study phases: a capacity based survey and an equipment map-
ping survey. Invited participants included national health authorities, heads of national 
reference laboratories and of public/private diagnostic laboratories in Serbia. Findings 
were analysed preliminarily and identified gaps were discussed, prioritized and validated 
through two ad hoc workshops involving all concerned institutions.  
Results. The Gap Assessment was performed between September and December 2017. 
The overall response rate was 69% for phase one and 74% for phase two. Identified gaps 
were assessed as highly relevant during the project workshops. 
Discussion. Gaps and priorities were highlighted, validated, and studied with a suitable 
level of detail to develop a concrete action-plan. The same methodological approach 
could be used to monitor progress in Serbia as well as in other EU candidate countries.


























cies and action plans, the International Health Regula-
tions (IHR), and technical standards through the use 
of indicators. The EULabCap comprises 38 indicators 
of laboratory capability and 22 of service capacity and 
is designed to be compiled in each country by one re-
spondent at the national level. About three quarters of 
the indicators are based on EU policy targets or inter-
national technical standards, while the remainder as-
sess EU surveillance and alert system contributions. 
The aim of this pilot was to explore the feasibility of all 
or part of the EULabCap indicators to identify pub-
lic health microbiology laboratory strengths, compare 
the mean scores for EU/EEA countries for each target 
and indicator, and explore vulnerabilities and possible 
areas for national or regional capacity strengthening 
activities. The study results were published in Febru-
ary 2017 [7]. Although the pilot was successful, several 
indicators of the EULabCap monitoring system were 
found not to be applicable to EU enlargement coun-
tries leading to an under-estimation of capacities and 
capabilities (mainly due to limited relevance of some 
indicators for countries not fully under EU surveillance 
obligations: e.g. indicators based on data reporting to 
TESSy or participation in activities of EU surveillance 
networks) [8].
As part of a Twinning Light project, the Italian Insti-
tute of Health (Istituto Superiore di Sanità – ISS) and 
the IPHS designed and conducted an in-depth Gap As-
sessment using a revised and adapted methodology to 
cater for the context and information needs of Serbian 
authorities. The aim of the TWL Gap Assessment study 
was to inform an overall implementation approach with 
a series of achievable initiatives for improving microbi-
ology diagnostic system quality in the function of sur-
veillance of communicable diseases in compliance with 
EU acquis and EU standards, by focusing on public and 
private microbiology laboratory diagnostic capacities 
and on the core functions and capacities of NRLs. This 
paper presents this methodological approach and dis-
cusses its relevance for Serbia and possibly other EU 
enlargement countries.
MATERIALS AND METHODS
The study was designed in two phases (Table 1). The 
first step included a capacity-based assessment on three 
functional levels: National System level, NRL core 
function level, and primary diagnostic level. The second 
step, restricted to responding public laboratories, was 
an equipment mapping survey. The capacity-based as-
sessment was designed as a cross-sectional survey with 
multiple respondents and was delivered, translated in 
Serbian, using an online questionnaire created with a 
specialized software called SurveyMonkey. Results were 
analysed using an ad hoc indicator framework (Supple-
mentary material S1).
Prior to developing the methodology, the following 
documents were analysed: laws, bylaws, rulebooks; 
prior relevant assessments/studies; lists and terms of 
reference of NRLs; existing laboratory assessment tools 
and relevant international legislation [4, 9, 10]. Based 
on this documentation and on the general objective of 
the Gap Assessment, the team developed goals for each 
functional level (Table 1).
Some of those goals aligned with the general struc-
ture of the EULabCap monitoring tool, which how-
ever was adapted and integrated to overcome the 
described limitations of this tool for countries in EU 
acceding status and to cater for the specific assessment 
requirements indicated by the Serbian authorities. In 
particular, Serbian partners stated that, to meet cur-
rent information gaps, the assessment should be able to 
provide in depth information on laboratory capacity by 
addressing laboratories individually and that targeted 
laboratories should include NRLs, primary diagnostic 
public laboratories as well as to primary diagnostic pri-
vate laboratories. The list of participating laboratories/
central institutions was compiled by the Serbian Min-
istry of Health (MoH) and IPHS and included: i) one 
respondent from the central health system level (MoH/
IPH); ii) all NRLs and iii) public diagnostic laboratories 
as well all the 40 private laboratories registered for in-
spection purposes with the MoH of Serbia.  
While the EULabCap tool is not designed to be 
Table 1 
General structure of the Gap Assessment (phase 1 and phase 2)
Phase Section Goal Function investigated Target group
1. Capacity-based 
assessment
1 To map system components 
of the microbiology system in 
the function of surveillance
System and central functions Ministry of Health / National Institute 
of Public Health 
2 To map core functions 
and capacities of National 
Reference Laboratories (NRLs)
Reference laboratory function 
to produce data/information for 
added public health value
National Reference Laboratories
3 To map public and private 
laboratory diagnostic 
capacities in microbiology
Microbiology testing to meet 
diagnostic needs for the clinical 
management of patients
All Public/Private laboratories 
performing primary diagnostic activity. 




To map availability of 
functional equipment in 
public laboratories
Reference laboratory function 
to produce data/information for 
added public health value and 
microbiology testing to meet 
diagnostic needs for the clinical 
management of patients
Public laboratories (including 
National Reference Laboratories) 
who responded to the phase 1 
questionnaire 
























compiled by a number of individual laboratories, this 
is the case for the World Health Organization (WHO) 
Laboratory assessment tool [11]. For this reason, the 
statements included in both the ECDC EULabCap 
and WHO tools, relevant to the study objective and to 
the goals identified, were extracted and integrated in a 
single word file. Statements addressing similar areas in 
the two tools were grouped. This document was then 
circulated among all project experts. During two meet-
ings in July 2017 in Belgrade, ISS and IPHS experts 
agreed upon the general methodology and on which 
statements to include in the TWL Gap Assessment 
study. 
The selected statements with predefined multiple-
choice answers were included in the capacity-based as-
sessment questionnaire. This questionnaire was divided 
in three different sections that were answered by dif-
ferent target groups (Table 1). These were introduced 
by an area in which respondent’s details were collected 
(including the name of the institution, its public/private 
status and if it was responding as the central health sys-
tem, as an NRL or as a diagnostic laboratory). The cen-
tral level answered only section one, NRLs answered 
sections two and three and primary diagnostic labora-
tories only section three. In this way, the questionnaire 
was able to cater for the fact that in Serbia, as in many 
other countries, NRLs have both a reference and a pri-
mary diagnostic role [12].
Section one focussed on System and Central Func-
tions including coordination mechanisms, laboratory 
networks, surveillance, quality assurance and biorisk 
management. 
Within section two, the implementation of core func-
tions of NRLs as defined by Serbian Law [3, 13] and 
by the ECDC [5] were explored. These functions were 
grouped as follows: 
• Function 1. Reference diagnostics;
• Function 2. Reference material resources; 
• Function 3. Scientific advice;
• Function 4. Collaboration and research;
• Function 5. Monitoring, alert and response.
In section three, primary diagnostic capacity as well 
as cross-functional issues such as infrastructure, labora-
tory equipment, IT (software and hardware), and hu-
man resources were assessed. For each pathogen un-
der EU surveillance as per Decision 2012/506/EU [4] 
for which laboratory criteria are defined (i.e. all except 
for the Creutzfeldt-Jakob disease variant), laboratories 
were asked to state whether they were able, as of 2016, 
to diagnose according to EU laboratory criteria and if 
they had in place agreements with other laboratories 
inside or outside Serbia to do so. An official transla-
tion in Serbian of the laboratory criteria for notifiable 
pathogens under Decision 2012/506/EU [4] was avail-
able as a link in this section of the questionnaire for 
reference.
To complement this broad capacity-based assessment 
with more in-depth information, all public laborato-
ries responding to the phase 1 questionnaire were also 
asked to participate in the second phase of the study 
and provide details of the equipment in place in their 
laboratories as of 2016.  This data was collected with a 
separate questionnaire, with the aim to map availability 
of functional equipment in public laboratories (Table 1).
Indicator framework
Once the statements in the Gap Assessment ques-
tionnaire and the content of the equipment mapping 
were defined and aligned to the study outcomes, in-
dicators able to measure the outcome were designed 
(Supplementary material S1). 
Subsequently achievement targets for each indicator 
were defined in alignment with EU formal standards if 
available (or EU expected proficiency level if not) by 
subject-matter experts from ISS. These included sci-
entific coordinators in charge of NRLs for each disci-
pline: bacteriology, virology, mycology and parasitology. 
When also applicable to a non-EU context, EULabCap 
indicators were maintained. Once drafted, indicators 
and targets were shared and agreed upon with experts 
of the IPHS. Indicators were then grouped in “com-
bined indicators” within each assessed outcome. This 
process led to the design of 148 indicators and targets 
(Supplementary material S1). The indicators were orga-
nized according to the study phases, sections and rela-
tive functions (Table 1). Within each function, relevant 
data were drawn from the different sections of the Gap 
Assessment questionnaire and of the equipment map-
ping questionnaire. In particular, the indicator frame-
work comprised of: 
• 26 indicators for function 1 (7 combined indicators); 
• 36 indicators for function 2 (7 combined indicators); 
• 77 indicators for function 3 and for cross-functional 
issues (10 combined indicators); 
• 9 indicators for equipment mapping (2 combined in-
dicators).
Validation of findings
Preliminary findings were validated in collaboration 
with experts of the IPHS during the entire project 
course as well as with the involved participants from 
concerned NRLs and diagnostic laboratories during 
two dedicated project workshops. 
Both workshops were organized identically. During 
the first part of the morning, the workshops included 
presentations aimed at sharing the experiences by Ital-
ian and Serbian partners on the workshop topics. Dur-
ing the rest of the day group work was performed. This 
group work was carried out according to a standard 
methodology. The aim of the group work was:
1. to share preliminary findings of the Gap Assessment;
2. to identify priority gaps.
More specifically, relevant preliminary findings of 
the analysis and identified gaps were shared with par-
ticipants to guide the subsequent group-work. Using 
a modified Delphi consensus generating methodology 
[14], the selected gaps were prioritized according to the 
following scoring criteria:
• the gap is an obstacle to implementing the new by-
laws aligning Serbian communicable disease surveil-
lance to EU acquis and EU standards;
• addressing this gap would support the development of 
sustainable institutional capacities to respond to seri-

























• the impact on improving the microbiology function 
of surveillance in Serbia through an activity target-
ing this gap would be high (i.e. generate sustainable 
results);
• an activity targeting this gap would be feasible in the 
current context;
• including an activity targeting this gap in a roadmap 
would generate wide consensus among stakeholders 
in Serbia. 
For each gap, participants were asked to score each 
of the above criteria from 1 (very unlikely) to 5 (very 
likely). Therefore, for each gap the minimum possible 
individual score was 5 and the maximum 25.  The gaps 
were scored in pairs by people not belonging to the 
same Institution to foster discussion. During the work-
shop coffee break, the scoring sheets were collected and 
analysed in real-time. The results were then presented 
in plenary and the identified priority gaps were selected. 
In advance of the workshops, Facilitators of IPHS 
and ISS were provided with a facilitator guide. Train-
ings and debriefings were organized the week before 
and the day after each workshop, respectively. One 
Serbian rapporteur per group was selected among the 
Facilitators in order to favour participation by leading 
discussions in the participants’ native language and best 
report back findings. The results of the discussions were 
used to substantiate and validate the Gap Assessment. 
Following the two workshops, the Gap Assessment 
dataset was analysed again by Italian Partners who 
prepared a preliminary report that was shared with the 
IPHS. Incoherent /dubious responses were identified 
and assessed by Serbian project partners who contacted 
when needed, by telephone, the contact points of the 
responding laboratory/ies. Incorrect responses due to a 
misinterpretation of the questionnaire statements were 
identified in this way and correct answers collected and 
inserted. The validated Gap Assessment dataset was 
downloaded on the 24th of November 2017. 
Data analysis
Categorical variables were summarized by absolute 
frequency and percentage and continuous variables by 
median and range. Each indicator was analysed as per 
the definitions the indicator document (Supplementary 
material S1). 
The following variables were categorized: number of 
patients/clients that had used microbiology services in 
2016; number of samples analysed in 2016 for bacteri-
ology, mycology, virology and parasitology, and number 
of staff present in the laboratories in 2016.
The number of patients/clients that had used microbi-
ology services in 2016 was used as a proxy of laboratory 
size and categorized as follows: 0-500; 501-10 000; 10 
001-25 000; 25 001-50 000 and > 50 000. The number 
of samples analysed in 2016 for bacteriology, mycology, 
virology and parasitology were respectively categorized 
as follows: 0-25 000; 25 001-50 000 and > 50 000.
The number of staff present in the laboratory was cat-
egorized as follows and stratified by profession and type 
of contract (permanent vs temporary): 0; 1-5 and > 5.
Equipment was grouped in the following catego-
ries: general equipment, biosafety equipment, serology 
equipment and molecular equipment depending on its 
use.
All analyses were performed using STATA software 
(version 11.2; StataCorp, College Station, Tex). Maps 
were constructed using the SPMAP STATA command. 
Shape files of the Republic of Serbia were downloaded 
from the GADM database [15], version 2.5, July 2015.
RESULTS 
The online questionnaire was piloted with Serbian 
project partners between the 6th and 12th of Septem-
ber 2017. Amendments were made based on their feed-
back to improve the clarity of statements and solve any 
technical issues that were found during the test. 
The online Gap Assessment survey was officially 
launched on the 28th of September 2017. After two 
weeks from the invitation, the Italian partners prepared 
a report for the Serbian partners, listing responders/
non-responders. The Italian partners also sent an au-
tomatic reminder to non-responders and to responders 
who had provided incomplete data. 
A week after this first reminder, the Italian partner 
provided a second report to the Serbian partners list-
ing responders/non-responders. A second reminder was 
sent to remaining non-responders and to responders 
who provided incomplete data. 
After one week, Italian partners informed Serbian 
partners of any remaining non-responders and incom-
plete responders. Alternative contact points and email 
addresses were added if needed. As a final reminder, 
Serbian partners tried to directly contact any remain-
ing non-responders and incomplete responders (via 
telephone or email) in order to increase response rates. 
The survey was officially closed on the 1st of November 
2017, 5 weeks after the first invitation.  
The overall response rate for the phase 1 study was 
69% (one respondent from the MoH/IPH central level 
and 97 laboratories). The responding laboratories in-
cluded all functioning NRLs, 94% of all public diag-
nostic laboratories and 33% of MoH registered pri-
vate diagnostic laboratories. The response rate for the 
phase two study was 74%, including 69% of all NRLs 
and 76% of phase one responding public diagnostic 
laboratories.
The two project workshops took place on the 31st of 
October and on the 6th of November 2017. The first 
targeted 50 participants from: the MOH, IPHS, Re-
gional Institutes of Public Health (RIPHs) and NRLs. 
The second workshop hosted 80 participants from the 
MOH, IPHS primary diagnostic microbiology labora-
tories (NRLs in their diagnostic function as well as ad-
ditional public/private laboratories). 
During the first workshop, preliminary results and the 
following tentative gaps for NRL functions were pre-
sented: 
• External Quality Assurance (EQA) not organized in 
all NRLs; 
• laboratory networks involving central, NRL and pe-
ripheral laboratories are not very strong; 
• performance of molecular methods for pathogen di-
agnosis and for outbreak investigation is not wide-
spread; 
























• lack of Guidelines and training for biosafety in the 
diagnostic labs; and 
• lack of a BSL3 laboratory in Serbia.
During the second workshop, Gap Assessment results 
were presented with a focus on the primary diagnostic 
function of microbiology laboratories. In this context, 
the following tentative gaps were presented: 
• laboratory networks involving central, NRL and pe-
ripheral laboratories are not very strong; 
• diagnostic capacity towards EU laboratory confirma-
tion criteria needs to be strengthened; 
• minimum standards for Biosafety in diagnostic labo-
ratories are missing; 
• External Quality Assurance (by NRL offering partici-
pation to diagnostic labs) for key pathogens is miss-
ing; 
• digitalization of information systems in microbiology 
in the function of surveillance is not widespread.
During the first workshop, 12 prioritization scoring 
sheets were submitted. The five gaps assessed scored on 
average between 20.5 and 22. As shown in Figure 1, the 
gap that was scored the highest was networking, albeit 
with the highest interquartile range (3.25). Following, 
there was the gap related to biosafety and at a similar 
level the gaps related to EQA and BLS3 laboratories. 
The performance of molecular methods for pathogen 
diagnosis and for outbreak investigation was scored the 
lowest.
During the second workshop, 27 scoring sheets were 
submitted. The five gaps assessed scored on average be-
tween 21 and 22. As shown in Figure 2, the gap that 
was scored the highest was gap 5: digitalization, albeit 
with the highest interquartile range (3.5). Following, 
there was the gap related to EQA followed, at a similar 
1st quartile score, by the gaps related to laboratory net-
works, diagnostic capacity and biosafety, although the 
latter had a higher interquartile range.
 
DISCUSSION 
The Gap Assessment study of the Serbian microbi-
ology system in the function of communicable disease 
surveillance was conducted with a methodology that in-
tegrated elements from the EULabCap tool [7] and the 
WHO laboratory capacity assessment tool [8] focussing 
mainly on reported capacity. 
Upon the Serbian authorities’ request, the study was 
designed to provide more in-depth information than 
the EULabCap tool by addressing individual labora-
tories. The study sample included both NRLs and pri-
mary diagnostic laboratories and, among those, also 
laboratories from the private sector. While trying to 
maintain as much as possible the EULabCap approach 
and statements, that are fully in line with EU standards 
and acquis, this study aimed to overcome the fact that 
not all those statements are appropriate to assess a 
country that is not yet fully part of the EU [7, 8]. At the 
same time, the Gap Assessment was designed to be less 
detailed than the WHO tool to allow for its relatively 
fast implementation. 
All phases of the methodology definition (including 
the design of the questionnaire and indicator frame-
work) were conducted with the support of senior 
subject-matter experts of the Serbian IPHS and of the 
Italian ISS. Statements were selected based on applica-
bility to the Serbian context and targets for the indica-
tors were set according to EU standards and practice. 
The two workshops planned during the TWL proj-
ect were implemented in the allotted timeframe. In 
Figure 1

























order for those opportunities of encounter with major 
stakeholders in the Serbian microbiology diagnostic 
and surveillance system to be conducive to validate the 
study findings, a standard methodology was developed. 
This approach required extensive advance preparation 
including the analysis of preliminary data of the Gap 
Assessment study, the preparation of group work ma-
terials and tools (e.g. prioritization criteria and the fa-
cilitator guide) and training of facilitators. However, on 
hindsight, this was a good investment. Both workshops 
were successfully carried out and generated relevant 
findings.
The prioritization exercise confirmed that all the 
gaps identified by the Gap Assessment study were 
highly relevant for participants with consistently very 
high median scores (between 20.5 and 22 over a maxi-
mum of 25). This finding validated the preliminary 
results of the study and indirectly confirmed that the 
Gap Assessment Methodology was successful in cap-
turing gaps of relevance to the Serbian microbiology 
system in the function of surveillance. This exercise 
also consistently highlighted areas of highest priority 
in the fields of networking, quality, biosafety and digi-
talization. These were the areas that were targeted in a 
road map and action plan that was delivered at the end 
of the project. 
The discussions, however, also identified some re-
current aspects ascribable to the common context of 
implementation that could not have been readily cap-
tured by the study questionnaires. These aspects were 
used as the backbone against which to analyse the 
main findings. Once elaborated, findings were assessed 
against prior assessment/ evaluation results [9, 16 ] and 
found to be consistent with the system’s development 
process. 
CONCLUSIONS
The methodology described in this paper was used 
to perform an in-depth assessment of the Serbian mi-
crobiology system in the function of communicable 
disease surveillance. Gaps and priorities were high-
lighted, validated, and studied with a suitable level of 
detail to develop a roadmap and a concrete action-
plan. Further, the entire study was designed, devel-
oped and conducted in less than 8 months, of which 
approximately four months from survey launch to re-
port submission. The indicator framework, through 
more detailed and adapted to a non EU context that 
the EULabCap, maintained its focus on EU standards 
and practice. Finally, the performance of two project 
workshops was useful in validating the gaps identified 
and prioritizing them. Discussion also added qualita-
tive information that guided the interpretation of the 
data collected. For these reasons, we believe this is a 
promising approach to the assessment of gaps in the 
function of surveillance of microbiology systems that 
could be used again in Serbia to monitor progress as 
well as in other EU acceding countries who need to 
produce similar outputs.
LIMITS
The time allocated for the conduction of this study 
was relatively short. Therefore, the analysis has focused 
on perceived capacity and needs from a wide microbiol-
ogy system perspective. 
Findings were based on self-reporting. As a conse-
quence, incorrect responses due to misinterpretation of 
questions or complacency/desirability bias are possible. 
However, as findings were repeatedly validated with 
stakeholders at central level (IPHS), NRL level and pri-
mary diagnostic level and as the identified gaps were 
Figure 2
Prioritization results of the second workshop, N=27.
























highly prioritized at all those levels, this methodologi-
cal limit should not have affected the overall validity of 
findings. 
By design, respondents were from laboratories under 
the jurisdiction of the Ministry of Health, from the Mil-
itary Medical Academy under jurisdiction of Ministry 
of Defence and from three NRLs under the Ministry of 
Science, Education and Technical development. How-
ever, this assessment could be more comprehensive if 
existing microbiological capacity in other sectors, such 
as Animal Health, could be also considered. 
The study by design addressed a wide number of is-
sues rather broadly, limiting the level of detail with 
which each issue could be assessed. When more in 
depth studies were considered necessary to guide spe-
cific policy decisions (e.g. provide indication on specific 
items of equipment to buy for individual laboratories), 
this was indicated in the final report. Given a longer 
timeframe, such studies, including audits, could have 
been included in the study itself.
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